Verition Fund Management
LUMO

Verition Fund Management’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Verition Fund Management’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-9,835
Closed -$351K – 1811
2020
Q4 		$351K Buy
+9,835
New +$170K ﹤0.01% 776
2020
Q1 		– Sell
-7,213
Closed -$164K – 1127
2019
Q4 		$164K Buy
+7,213
New +$103K ﹤0.01% 992

Other funds holding LUMO

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Verition Fund Management's LUMO Position: Q1 2021 in Review

Verition Fund Management sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q1 2021, closing a stake of 9,835 shares — an estimated $351K sold.

Verition Fund Management first reported a position in LUMO in Q4 2019 and held it in 2 quarters. The position peaked at $351K in Q4 2020. 41 funds tracked by Wall St. Rank hold LUMO as of Q1 2021.

  • Verition Fund Management reported no remaining Lumos Pharma, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Verition Fund Management sold 9,835 Lumos Pharma, Inc. Common Stock shares in Q1 2021, an estimated $351K.
  • Verition Fund Management first reported a position in Lumos Pharma, Inc. Common Stock in Q4 2019 and held it in 2 quarters.
  • Verition Fund Management's Lumos Pharma, Inc. Common Stock position peaked at $351K in Q4 2020.
  • 41 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q1 2021.

Based on Verition Fund Management's 13F filing for Q1 2021, filed 18 May 2021.